Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2012 14:45 ET | Source: MediWound Ltd.

MediWound -- Positive Recommendation for Marketing Authorization From the European Medicines Agency for Its Innovative Drug -- NexoBrid(TM)

TEL AVIV, Israel, Sept. 24, 2012 (GLOBE NEWSWIRE) -- Clal Biotechnology, (TASE:CBI), a leading investment company in the field of life sciences, is pleased to announce that the Committee for Medicinal...